Healthcare provider profile · identity verified

Robert I Steward, MD

Family Practice · ASHEVILLE, NC · NPI 1194777474

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	384	111
Atorvastatin Calcium	Atorvastatin Calcium	367	103
Pantoprazole Sodium	Pantoprazole Sodium	300	86
Amlodipine Besylate	Amlodipine Besylate	298	85
Losartan Potassium	Losartan Potassium	295	82
Hydrochlorothiazide	Hydrochlorothiazide	259	74
Lisinopril	Lisinopril	259	74
Levothyroxine Sodium	Levothyroxine Sodium	251	63
Trazodone Hcl	Trazodone Hcl	231	54
Omeprazole	Omeprazole	213	66
Metoprolol Succinate	Metoprolol Succinate	190	50
Metformin Hcl Er	Metformin Hcl	189	51
Escitalopram Oxalate	Escitalopram Oxalate	171	44
Famotidine	Famotidine	167	50
Gabapentin	Gabapentin	164	47
Tramadol Hcl	Tramadol Hcl	148	31
Pravastatin Sodium	Pravastatin Sodium	138	34
Simvastatin	Simvastatin	131	35
Metoprolol Tartrate	Metoprolol Tartrate	120	27
Sertraline Hcl	Sertraline Hcl	105	31
Meloxicam	Meloxicam	102	25
Albuterol Sulfate Hfa	Albuterol Sulfate	100	35
Duloxetine Hcl	Duloxetine Hcl	99	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	98	15
Eliquis	Apixaban	92	24
Furosemide	Furosemide	92	34
Fluticasone Propionate	Fluticasone Propionate	84	30
Tamsulosin Hcl	Tamsulosin Hcl	81	25
Pregabalin	Pregabalin	76	16
Ezetimibe	Ezetimibe	73	19
Potassium Chloride	Potassium Chloride	73	15
Doxepin Hcl	Doxepin Hcl	70	15
Synthroid	Levothyroxine Sodium	65	15
Arexvy	Rsvpref3 Antigen/As01e/Pf	64	64
Oxycodone Hcl	Oxycodone Hcl	64	suppressed
Donepezil Hcl	Donepezil Hcl	61	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	61	17
Allopurinol	Allopurinol	60	15
Alprazolam	Alprazolam	60	16
Citalopram Hbr	Citalopram Hydrobromide	59	14
Prednisone	Prednisone	58	39
Spironolactone	Spironolactone	57	15
Jardiance	Empagliflozin	56	suppressed
Alendronate Sodium	Alendronate Sodium	53	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	50	13
Metformin Hcl	Metformin Hcl	50	13
Mirtazapine	Mirtazapine	49	12
Montelukast Sodium	Montelukast Sodium	49	15
Shingrix	Varicella-Zoster Ge/As01b/Pf	49	41
Buspirone Hcl	Buspirone Hcl	48	suppressed
Clopidogrel	Clopidogrel Bisulfate	48	16
Triamcinolone Acetonide	Triamcinolone Acetonide	48	34
Bupropion Hcl Sr	Bupropion Hcl	46	11
Zolpidem Tartrate	Zolpidem Tartrate	46	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	44	12
Carvedilol	Carvedilol	43	14
Venlafaxine Hcl Er	Venlafaxine Hcl	41	suppressed
Lorazepam	Lorazepam	38	13
Xarelto	Rivaroxaban	36	suppressed
Symbicort	Budesonide/Formoterol Fumarate	35	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	34	12
Cefdinir	Cefdinir	30	28
Nitroglycerin	Nitroglycerin	30	18
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	29	29
Doxazosin Mesylate	Doxazosin Mesylate	29	suppressed
Finasteride	Finasteride	29	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	29	suppressed
Cephalexin	Cephalexin	28	25
Ozempic	Semaglutide	28	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	26	26
Valsartan	Valsartan	26	suppressed
Tizanidine Hcl	Tizanidine Hcl	25	13
Celecoxib	Celecoxib	24	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	24	22
Esomeprazole Magnesium	Esomeprazole Magnesium	24	suppressed
Glimepiride	Glimepiride	24	suppressed
Nabumetone	Nabumetone	23	suppressed
Nystatin	Nystatin	23	12
Warfarin Sodium	Warfarin Sodium	23	suppressed
Amoxicillin	Amoxicillin	21	17
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Bydureon Bcise	Exenatide Microspheres	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Bumetanide	Bumetanide	18	suppressed
Fenofibrate	Fenofibrate	18	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	18	suppressed
Solifenacin Succinate	Solifenacin Succinate	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Baclofen	Baclofen	17	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Lansoprazole	Lansoprazole	17	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Tresiba Flextouch U-100	Insulin Degludec	17	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	11
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	11
Premarin	Estrogens, Conjugated	14	suppressed
Atenolol	Atenolol	13	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Mometasone Furoate	Mometasone Furoate	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Azithromycin	Azithromycin	12	12
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Fosinopril Sodium	Fosinopril Sodium	12	suppressed
Naproxen	Naproxen	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Glipizide	Glipizide	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Novolog	Insulin Aspart	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error